Given that CD/LD therapy for PD is highly individualized, what are possible advantages of longer-acting formulations of CD/LD and/or the availability of a scored, fractionable formulation of CD/LD highly amenable to titration?

Given that CD/LD therapy for PD is highly individualized, what are possible advantages of longer-acting formulations of CD/LD and/or the availability of a scored, fractionable formulation of CD/LD highly amenable to titration?

Given that CD/LD therapy for PD is highly individualized, what are possible advantages of longer-acting formulations of CD/LD and/or the availability of a scored, fractionable formulation of CD/LD highly amenable to titration by the patient or the physician?


Created by

CMEducation Resources iQ&A Parkinson’s Disease (PD) Medical Intelligence Zone

Related Presenters

Hubert Fernandez, MD

Hubert Fernandez, MD

Center for Neurological Restoration Professor of Medicine (Neurology) Cleveland Clinic Lerner College of Medicine Case Western Reserve University Neurological Institute, Cleveland Clinic Cleveland, Ohio